E. Glusa et al., INHIBITION OF THROMBIN-MEDIATED CELLULAR EFFECTS BY TRIABIN, A HIGHLYPOTENT ANION-BINDING EXOSITE THROMBIN INHIBITOR, Thrombosis and haemostasis, 77(6), 1997, pp. 1196-1200
Triabin, a 17 kDa protein from the saliva of the assassin bug Triatoma
pallidipennis is a potent thrombin inhibitor interfering with the ani
on-binding exosite of the enzyme. The recombinant protein, produced by
the baculovirus/insect cell system, was used to study the inhibitory
effect on thrombin-mediated cellular responses. The thrombin (1 nM)-st
imulated aggregation of washed human platelets and the rise in cytopla
smic calcium in platelets were inhibited by triabin at nanomolar conce
ntrations. In contrast, the rise in calcium induced by the thrombin re
ceptor-activating peptide (10 mu M) was not suppressed by triabin. In
isolated porcine pulmonary arteries, preconstricted with PGF(2 alpha),
thrombin (2 nM) elicited an endothelium-dependent relaxation which wa
s inhibited by triabin in the same concentration range as found for th
e inhibition of platelet aggregation. Higher concentrations of triabin
were required to diminish the contractile response of endothelium-den
uded pulmonary vessels to thrombin (10 nM). In cultured bovine coronar
y smooth muscle cells, the mitogenic activity of thrombin (3 nM), meas
ured by [H-3]thymidine incorporation, was also suppressed by triabin.
In all these assays, the inhibitory effect of triabin was dependent on
the thrombin concentration used. These studies suggest that the new a
nion-binding exosite thrombin inhibitor triabin is one of the most pot
ent inhibitors of thrombin-mediated cellular effects.